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Incubation of intact human erythrocytes with [3H]palmitate labeled a protein with electrophoretic characteristics of the glucose transporter. This 
labeling occurred via a thioester linkage, since it was unaffected by organic solvent extraction, but was substantially removed as the hydroxamate 
upon treatment with neutral hydroxylamine. Immunoprecipitation of the labeled protein with a monoclonal ntibody to the glucose transporter 
confirmed its identity. 
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1. INTRODUCTION 
Thio l - fatty  acylat ion is one o f  several mechanisms by 
which p lasma membrane proteins may be covalently 
l inked to l ipid [1,2]. This process is post-translat ional ,  
and occurs even in mature erythrocytes,  in which acyla- 
t ion by [3H]palmitate has been reported for ankyr in [3], 
the anion t ransporter  [4], the Rh(D) antigen [5], and an 
unident i f ied Mr= 53-55000 protein [5,6]. A major  
cr i ter ion for such acylat ion is fai lure to remove 
[3H]palmitate by organic solvent extract ion or upon 
separat ion of  membrane proteins and l ipid during 
sod ium dodecyl su l fate-polyacry lamide gel elec- 
t rophores is  [1,2,7]. The presence of  a thioester ather 
than a carboxyl ic  ester or amide is shown by labi l ity of  
the l inkage to treatment with neutral  hydroxylamine,  
associated with the format ion  of  [3H]palmitohydrox-  
amate  [1,2,7]. 
The human erythrocyte glucose transporter  is a l ikely 
candidate for thiol - fatty acylat ion, since it is an ex- 
t remely hydrophobic  mult i -spanning membrane protein 
[8], which contains ix cysteine residues [8], only five of  
which are reactive with N-[~H]ethylmaleimide under 
strong denatur ing condit ions [9]. Furthermore,  
Staufenbiel  [6] has shown that [3H]palmitate labeling of  
erythrocyte ghosts occurs in the broad band 4.5 
t ransporter  egion (nomenclature o f  Fa i rbanks et al 
[10]) on polyacry lamide gel electrophoresis.  Because of  
the potent ial  contr ibut ion of  such a l inkage to anchor-  
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ing o f  a protein in the membrane,  or to its funct ional  
regulat ion [1,2,11], the possibi l i ty that the glucose 
t ransporter  is th io l - fatty acylated was investigated in 
human erythrocytes. 
2. EXPERIMENTAL 
Human erythrocytes were obtained and prepared as described 
previously [12] using buffer containing l0 mM Hepes, 135 mM NaCl, 
2.2 mM KC1, 2.1 mM MgSO4, 2.5 mM CaC12, 1.5 mM KH2PO4, 10 
mg/ml bovine serum albumin, and 5 mM D-glucose, pH 7.4. Incuba- 
tions were initiated by adding 25 #Ci of [9,10-3H]palmitic a id (30 
Ci/mmol, New England Nuclear) to each ml of 50% cells. The labeled 
palmitic acid was dissolved in ethanol, the final fraction of which 
never exceeded 1%. Incubations were carried out for 2 h at 37°C with 
gentle agitation and terminated by 3 centrifugation washes in 20 vols 
of the same buffer. Labeled cells were lysed immediately, eaky ghost 
membranes prepared [10], and these depleted of extrinsic membrane 
proteins as described by Gorga and Lienhard [13]. Purified glucose 
transporter was prepared as described by Baldwin et al. [14]. The 
labeled glucose transport protein was immunoprecipitated from 
purified band 4.5 as described by Tai and Carter-Su [15], using 
monoclonal ntibody 7F7.5 coupled to Protein A-Sepharose CL-4B 
[16]. 
Radiolabeled protein was subjected to slab-gel sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis as previously described 
[17,18]. Following electrophoresis, the gels were treated by one of 
several methods. Some lanes were sliced into 1.9 mm sections for 
radioactive counting [18]. Others were extracted with 
chloroform/methanol (2:1) to remove noncovalently attached 
[3H]palmitate [3]. Additional lanes were incubated with 1 M 
NHEOH • HCI, pH 6.6, for 2 h at 23°C to cleave thiol esters [19], and 
then sliced for radioactive counting. For determination f hydrox- 
ylamine cleavage products from the glucose carrier egion, following 
electrophoresis the band 4.5 region was identified by the location of 
prestained standards (Bethesda Research Laboratories, Gaithersburg, 
MD), cut from an entire gel, and treated as above with hydrox- 
ylamine. The hydroxylamine-cleavage products were isolated as 
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described by Schlesinger t al. [20]: the hydroxylamine buffer was ex- 
tracted three times with equal volumes of chloroform/methanol (2:1), 
the extracts were dried under nitrogen, the residue was redissolved in 
chloroform/methanol (1:1), and a sample was mixed with 50-100 #g 
of palmitohydroxamic a id, prepared as described by Heusser [21]. 
Thin-layer chromatography was carried out on an aliquot of this solu- 
tion using silica gel G plates developed in toluene/chloroform/ 
acetone (1:1:1). Carrier hydroxamate was detected by spraying with 
0.7070 FeCI3 in methanol/ether/water (45:45:10) containing 0.7507o 
HCI [21]. Radioactivity was quantitated by scraping 0.5 mm sections 
of the gel lanes from the plate, adding 0.5 ml of water, and counting 
in 5 ml of Poly-Fluor (Packard Instrument Co.). In this thin-layer sol- 
vent system the Rt of palmitohydroxamate was 0.2, and that of 
[3H]palmitic acid was 0.5. 
3. RESULTS 
Purified glucose transport protein from cells in- 
cubated with [3H]palmitate showed labeling of a broad 
peak in the band 4.5 region corresponding to that ex- 
pected for the glucose transporter [14]. Although not 
clearly separated from the tracking dye in the 8°7o 
acrylamide gel of Fig. 1, labeling of a band in the 
Mr = 28-32000 region was also prominent in 10°70 gels. 
This region did not correspond to band 7, which could 
be seen in adjacent Coomassie brilliant blue-stained gel 
lanes (not shown). Neither peak was appreciably 
decreased by extraction of the gel with chloroform/ 
methanol (not shown). 
The nature of the linkage between [3H]palmitate and 
the labeled band 4.5 protein was determined by treat- 
ment with hydroxylamine at pH 6.6, which cleaves 
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Fig. 1. Electrophoretic pattern of [3H]palmitate-labeled purified band 
4.5 and effects of neutral hydroxylamine treatment. Band 4.5 was 
purified from [3H]palmitate-labeled erythrocytes and incubated in 50 
mM Tris containing 1 mM EDTA and 150 mM NaCI, pH 7.4, without 
(closed circles) or with (open circles) 1 M hydroxylamine, for 2 h at 
23°C. The incubation was terminated by a 15-fold dilution and 
centrifugation for 1 h at 100000xg. Electrophoresis of 100/zg of 
untreated, and 200/zg of hydroxylamine-treated band 4.5 pellets was 
performed across several lanes of an 8°70 acrylarnide gel. 
Hydroxylamine treatment of purified band 4.5 before 
electrophoresis resulted in loss of radioactive label from 
all the major peaks, including band 4.5 (Fig. 1). This 
loss was even greater than directly apparent in Fig. 1, 
since twice the amount of hydroxylamine-treated band 
4.5 protein was applied to the electrophoretic gel. 
Similarly, when purified band 4.5 was subjected to 
polyacrylamide gel electrophoresis, ubsequent treat- 
ment of the intact gel with hydroxylamine r sulted in 
the same cleavage pattern and loss of radioactivity (not 
shown). Hydroxylamine treatment decreased the band 
4.5 radioactivity by 50-70°70 in the several experiments 
performed. The nature of the hydroxylamine-cleavage 
products was studied by cutting the band 4.5 region 
from a similar gel, treating it with neutral hydrox- 
ylamine, extracting the resulting supernatant with 
chloroform/methanol (2:1), and identifying the 
radiolabeled products by thin-layer chromatography. 
In a typical chromatogram, 60-70°/0 of the radioactive 
extract was identified as palmitohydroxamate and a 
small amount of palmitic acid (not shown). Taken 
together, these results indicate that most of the labeling 
in the band 4.5 glucose transporter egion of elec- 
trophoretic gels involves thioester linkages. 
Thiol-fatty acylation of the glucose transporter was 
confirmed by its immunoprecipitation from a purified 
band 4.5 preparation derived from cells which had been 
labeled with [~H]palmitate. As shown in Fig. 2, im- 
munoprecipitation with monoclonal antibody 7F7.5, 
which in this preparation should bind only the glucose 
transporter [15], did result in a labeled peak in the band 
4.5 region upon subsequent electrophoresis of the im- 
munoprecipitate. Immunoprecipitation with a control 
monoclonal antibody did not yield a labeled band 4.5 
peak (Fig. 2). 
DPM 
(x I02) 
I zoo,ooo ' ioo,ooo 'r~,ooo 4s;,ooo 'eZooo ' ,s,oo ;o 
81 I I I 1 1 ! 
l/I ioj 4 ~ 
GEL SL,CE NUMBER 
Fig. 2. Immunoprecipitation of [3H]palmitate-labeled glucose 
transporter. A purified band 4.5 preparation from erythrocytes which 
had been labeled with [3H]palmitate was immunoprecipitated with 
monoclonal antibody 7F7.5 (closed circles) or a non-specific 
monoclonal antibody (open circles), and 20 /~g were subjected to 
electrophoresis on a 10070 acrylamide gel. 
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4. DISCUSSION 
The major finding of this work is that the glucose 
transport protein of human erythrocytes i thiol-fatty 
acylated. By analogy with other proteins [1,2,4,5], this 
feature may contribute to its hydrophobic nature, its 
tendency to aggregate in denatured form, and to dif- 
ficulties encountered in its purification [14,22,23]. 
Although the purified band 4.5 prepared as described 
herein consists of about 70-80% glucose transporter 
relative to other proteins retained in the endogenous 
lipid micelles [14], it is known to be contaminated with 
the nucleoside transporter in the Mr = 43-66000 range, 
and with band 7 [14,15]. Since the [~H]palmitate- 
labeled peak in the Mr = 43-66000 glucose transporter 
region could reflect labeling of the former, proof that 
the glucose transporter was indeed labeled required its 
specific immunoprecipitation. This was accomplished 
with monoclonal antibody 7F7.5, which has been 
shown by Tai and Carter-Su [15] to differentiate be- 
tween the two transporters. 
In purified band 4.5, a second [3H]palmitate-labeled 
peak was observed on electrophoretic gels. This band 
varied in apparent molecular weight with the 
acrylamide concentration of the gel, usually appearing 
as a peak and shoulder, ranging from Mr= 28-32000 
(Fig. 1). This region contains the Rh antigens, and the 
Rh(D) antigen is known to be fatty acylated under these 
conditions [5]. The Rh proteins, like the glucose 
transporter, are also quite hydrophobic and may be re- 
tained in the purified band 4.5 preparation. The peak 
was not present in electrophoreses of immunopreci- 
pitated glucose carrier (Fig. 2). 
The cysteine(s) in the glucose transporter involved in 
thiol-ester formation were not determined in the present 
study. Deziel et al. [9] have shown that of the six cys- 
teines in the erythrocyte glucose transport protein [8], 
only five are susceptible to labeling by N- 
ethylmaleimide under denaturing conditions. The resis- 
tant cysteine is in the Mr = 19000 nonglycosylated tryp- 
tic fragment [9], which also contains an exofacial 
sulfhydryl reactive with impermeant maleimides 
[24,25]. In other thiol-fatty acylated proteins, a com- 
mon location for the involved cysteine is on a 
cytoplasmic segment relatively near the membrane 
[1,2]. This location apparently serves the function of 
tethering the segment to the membrane. In the 
Mr= 23-40000 glycosylated tryptic fragment of the 
glucose transporter, hydropathy analysis suggests that 
Cys-207 is located very close to the lipid bilayer on the 
large cytoplasmic loop [8], so that this may be a plausi- 
ble site for thioester formation. Additional proteolytic 
digestion studies are indicated to further localize the 
labeled sulfhydryl(s). 
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